IBRNvsIJH
iShares Neuroscience and Healthcare ETF against iShares Core S&P Mid-Cap ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBRN | IJH | |
|---|---|---|
| Expense ratio | 0.47% | 0.050% |
| Assets | $7931.50T | $126.5B |
| Net flow, 1 month | +$2M | +$742M |
| Net flow, 1 year | +$2M | +$7.6B |
| Return, YTD | +27.9% | +15.1% |
| Return, 1 year | +68.6% | +20.7% |
| Avg daily volume | 3K | 5.9M |
| Holdings | 54 | 415 |
| Listed | Aug 23, 2022 | May 21, 2000 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS